Helicobacter pylori infection and the risk of gastric carcinoma.

BACKGROUND Infection with Helicobacter pylori has been linked with chronic atrophic gastritis, an inflammatory precursor of gastric adenocarcinoma. In a nested case-control study, we explored whether H. pylori infection increases the risk of gastric carcinoma. METHODS From a cohort of 128,992 persons followed since the mid-1960s at a health maintenance organization, 186 patients with gastric carcinoma were selected as case patients and were matched according to age, sex, and race with 186 control subjects without gastric carcinoma. Stored serum samples collected during the 1960s were tested for IgG antibodies to H. pylori by enzyme-linked immunosorbent assay. Data on cigarette use, blood group, ulcer disease, and gastric surgery were obtained from questionnaires administered at enrollment. Tissue sections and pathology reports were reviewed to confirm the histologic results. RESULTS The mean time between serum collection and the diagnosis of gastric carcinoma was 14.2 years. Of the 109 patients with confirmed gastric adenocarcinoma (excluding tumors of the gastroesophageal junction), 84 percent had been infected previously with H. pylori, as compared with 61 percent of the matched control subjects (odds ratio, 3.6; 95 percent confidence interval, 1.8 to 7.3). Tumors of the gastroesophageal junction were not linked to H. pylori infection, nor were tumors in the gastric cardia. H. pylori was a particularly strong risk factor for stomach cancer in women (odds ratio, 18) and blacks (odds ratio, 9). A history of gastric surgery was independently associated with the development of cancer (odds ratio, 17; P = 0.03), but a history of peptic ulcer disease was negatively associated with subsequent gastric carcinoma (odds ratio, 0.2; P = 0.02). Neither blood group nor smoking history affected risk. CONCLUSIONS Infection with H. pylori is associated with an increased risk of gastric adenocarcinoma and may be a cofactor in the pathogenesis of this malignant condition.

[1]  K. Jaskiewicz,et al.  The association of Campylobacter pylori with mucosal pathological changes in a population at risk for gastric cancer. , 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[2]  M. Blaser,et al.  Seroprevalence of Helicobacter pylori infections in Thailand. , 1990, The Journal of infectious diseases.

[3]  G. Friedman,et al.  Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. , 1986, American journal of epidemiology.

[4]  S Greenland,et al.  A general estimator for the variance of the Mantel-Haenszel odds ratio. , 1986, American journal of epidemiology.

[5]  P. Quirke,et al.  Helicobacter gastritis and intestinal metaplasia in a gastric cancer family , 1990, The Lancet.

[6]  A. Siegelaub,et al.  Cigarettes, alcohol, coffee and peptic ulcer. , 1974, The New England journal of medicine.

[7]  R. Detels,et al.  Epidemiology of gastric cancer in Chile: I - Case-control study. , 1981, International journal of epidemiology.

[8]  P. Brown,et al.  Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. , 1989, Journal of clinical pathology.

[9]  R. Doll,et al.  The Epidemiology of Cancer , 1980, Cancer.

[10]  J. Arends,et al.  Helicobacter pylori and gastric carcinoma , 1990, Histopathology.

[11]  D. Graham,et al.  A sensitive and specific serologic test for detection of Campylobacter pylori infection. , 1989, Gastroenterology.

[12]  M. Blaser,et al.  Campylobacter pylori antibodies in humans. , 1988, Annals of internal medicine.

[13]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[14]  D. Amadori,et al.  A case‐control study of gastric cancer and diet in Italy: II. Association with nutrients , 1990, International journal of cancer.

[15]  D M Parkin,et al.  Estimates of the worldwide frequency of sixteen major cancers in 1980 , 1988, International journal of cancer.

[16]  P. Correa Clinical implications of recent developments in gastric cancer pathology and epidemiology. , 1985, Seminars in oncology.

[17]  E. Fontham,et al.  Gastric precancerous process in a high risk population: cohort follow-up. , 1990, Cancer research.

[18]  B. Ames,et al.  Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.

[19]  R. Sampliner,et al.  Barrett's esophagus: a model premalignant lesion for adenocarcinoma. , 1989, Preventive medicine.

[20]  E. Wynder,et al.  The decline in gastric cancer: epidemiology of an unplanned triumph. , 1986, Epidemiologic reviews.

[21]  L. F. Fajardo,et al.  Diet and gastric cancer: nutrition survey in a high-risk area. , 1983, Journal of the National Cancer Institute.

[22]  B. Marshall,et al.  Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. , 1987, The Journal of infectious diseases.

[23]  D. Forman,et al.  Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China , 1990, International journal of cancer.

[24]  N. Muñoz,et al.  Histologic types of gastric carcinoma in high‐ and low‐risk areas , 1968, International journal of cancer.

[25]  E. Fontham,et al.  Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. , 1989, The American journal of gastroenterology.

[26]  J. Parsonnet,et al.  Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. , 1991, Journal of the National Cancer Institute.

[27]  P. Correa,et al.  Gastric cancer in Colombia. III. Natural history of precursor lesions. , 1976, Journal of the National Cancer Institute.

[28]  M. Collins,et al.  Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., Respectively , 1989 .

[29]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[30]  M. Faulde,et al.  Evaluation of an immunofluorescence assay for specific detection of immunoglobulin G antibodies directed against Helicobacter pylori, and antigenic cross-reactivity between H. pylori and Campylobacter jejuni , 1991, Journal of clinical microbiology.

[31]  C. Compton,et al.  Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. , 1990, The American journal of medicine.

[32]  P. Sipponen,et al.  Decreased incidences of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period. , 1987, Scandinavian journal of gastroenterology.

[33]  P. Correa,et al.  Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. , 1970, Journal of the National Cancer Institute.

[34]  P. Correa,et al.  Epidemiology of Gastric Cancer , 1982 .

[35]  R. Macholz Cancer Occurrence in Developing Countries (IARC Scientific Publications No. 75). Herausgegeben von D. M. Parkin. 339 Seiten. 184 Tab. International Agency for Research on Cancer, Lyon 1986. Preis: 20,— £ , 1988 .

[36]  W. Haenszel,et al.  Stomach cancer among Japanese in Hawaii. , 1972, Journal of the National Cancer Institute.